Is an extended 20-core prostate biopsy protocol more efficient than the standard 12-core? A randomized multicenter trial

Journal of Urology

Volumn 190, Issue 1, 2013, Pages 77-83

  Irani, Jacques ^a   Blanchet, Pascal ^b   Salomon, Laurent ^c   Coloby, Patrick ^d   Hubert, Jacques ^e   Malavaud, Bernard ^f   Mottet, Nicolas ^g  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b Centre Hospitalier Universitaire Pointe a Pitre   (Guadeloupe)

^c HENRI MONDOR HOSPITAL   (France)

^d Pontoise Hospital   (France)

^e UNIVERSITY HOSPITAL OF NANCY   (France)

^f TOULOUSE UNIVERSITY HOSPITAL   (France)

^g Clinique Mutualiste   (France)

Author keywords

biopsy, needle; diagnosis; prostate; prostatic neoplasms; ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER DIAGNOSIS; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HEMATURIA; HEMOSPERMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; RECTUM HEMORRHAGE; SELF EVALUATION; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; BIOPSY, LARGE-CORE NEEDLE; BIOPSY, NEEDLE; CONFIDENCE INTERVALS; DIGITAL RECTAL EXAMINATION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 84878857467     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.12.109     Document Type: Article

References (20)

1. A. Heidenreich, J. Bellmunt, M. Bolla European Association of Urology EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 2011 61
2. K. Eichler, S. Hempel, J. Wilby Diagnostic value of systematic biopsy methods in the investigation of prostate cancer: a systematic review J Urol 175 2006 1605
3. A. de la Taille, J.S. Jones, E.A. Klein Open to debate The motion: at least 18 cores are necessary to make a prostatic biopsy useful Eur Urol 53 2008 659
4. G. Ploussard, C. Marchand, N. Nicolaiew Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy Eur Urol 2012 Epub ahead of print
5. T.T. Abd, M. Goodman, J. Hall Comparison of 12-core versus 8-core prostate biopsy: multivariate analysis of large series of US veterans Urology 77 2011 541
6. C.K. Naughton, D.C. Miller, D.E. Mager A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection J Urol 164 2000 388
7. P. Mariappan, W.L. Chong, M. Sundram Increasing prostate biopsy cores based on volume vs the sextant biopsy: a prospective randomized controlled clinical study on cancer detection rates and morbidity BJU Int 94 2004 307
8. R. Paul, S. Schöler, H. van Randenborgh Optimization of prostatic biopsy: a prospective randomized trial comparing the sextant biopsy with a 10-core biopsy. Impact of prostatic region of sampling Urol Int 74 2005 203
9. J.J.M.C.H. de la Rosette, M.H. Wink, C. Mamoulakis Optimizing prostate cancer detection: 8 versus 12-core biopsy protocol J Urol 182 2009 1329
10. M.A. Rochester, S. Griffin, B. Chappell A prospective randomised trial of extended core prostate biopsy protocols utilizing 12 versus 15 cores Urol Int 83 2009 155
11. F. Rodríguez-Covarrubias, A. González-Ramírez, B. Aguilar-Davidov Extended sampling at first biopsy improves cancer detection rate: results of a prospective, randomized trial comparing 12 versus 18-core prostate biopsy J Urol 185 2011 2132
12. A. Lecuona, C.F. Heyns A prospective, randomized trial comparing the Vienna nomogram to an eight-core prostate biopsy protocol BJU Int 108 2011 204
13. D. Mitropoulos, W. Artibani, M. Graefen European Association of Urology Guidelines Panel Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU guidelines panel assessment and recommendations Eur Urol 61 2012 341
14. C.H. Bangma, M. Bul, M. Roobol The Prostate cancer Research International: Active Surveillance study Curr Opin Urol 22 2012 216
15. M. Remzi, Y.K. Fong, M. Dobrovits The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume J Urol 174 2005 1256
16. S.F. Oon, R.W. Watson, J.J. O'Leary Epstein criteria for insignificant prostate cancer BJU Int 108 2011 518
17. S. Loeb, S. van den Heuvel, X. Zhu Infectious complications and hospital admissions after prostate biopsy in a European randomized trial Eur Urol 61 2012 1110
18. C.K. Naughton, D.K. Ornstein, D.S. Smith Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores J Urol 163 2000 168
19. R. Paul, S. Schöler, H. van Randenborgh Morbidity of prostatic biopsy for different biopsy strategies: is there a relation to core number and sampling region? Eur Urol 45 2004 450
20. C.K. Naughton, D.C. Miller, Y. Yan Impact of transrectal ultrasound guided prostate biopsy on quality of life: a prospective randomized trial comparing 6 versus 12 cores J Urol 165 2001 100